FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We have now added a new section called the "Assay History List" to the "At A Gla...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...